4//SEC Filing
DEPPE MICHAEL J 4
Accession 0001022079-24-000204
CIK 0001022079other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 5:21 PM ET
Size
22.9 KB
Accession
0001022079-24-000204
Insider Transaction Report
Form 4
DEPPE MICHAEL J
SVP, Corp. Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$71.17/sh+8,635$614,553→ 43,576 total - Sale
Common Stock
2024-11-06$152.70/sh−2,100$320,676→ 51,596 total - Sale
Common Stock
2024-11-06$154.74/sh−4,135$639,833→ 45,061 total - Sale
Common Stock
2024-11-06$154.03/sh−2,331$359,046→ 40,130 total - Exercise/Conversion
Common Stock
2024-11-06$66.51/sh+10,120$673,081→ 53,696 total - Sale
Common Stock
2024-11-06$153.98/sh−2,400$369,559→ 49,196 total - Sale
Common Stock
2024-11-06$152.71/sh−2,600$397,050→ 42,461 total - Sale
Common Stock
2024-11-06$154.74/sh−5,189$802,958→ 34,941 total - Exercise/Conversion
Non-Qualifed Stock Option (right to buy)
2024-11-06$71.17/sh−8,635$614,553→ 0 totalExercise: $71.17Exp: 2025-02-23→ Common Stock (8,635 underlying) - Exercise/Conversion
Non-Qualifed Stock Option (right to buy)
2024-11-06$66.51/sh−10,120$673,081→ 0 totalExercise: $66.51Exp: 2026-02-25→ Common Stock (10,120 underlying)
Holdings
- 691(indirect: By 401(k))
Common Stock
Footnotes (10)
- [F1]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- [F10]The options vested in three annual installments beginning with the first on February 26, 2017, the second on February 25, 2018 and the final on February 25, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $152.400 to $153.200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $154.460 to $155.180. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $152.400 to $153.170. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $154.460 - $155.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- [F8]These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- [F9]The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.
Documents
Issuer
QUEST DIAGNOSTICS INC
CIK 0001022079
Entity typeother
Related Parties
1- filerCIK 0001771759
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 5:21 PM ET
- Size
- 22.9 KB